The Confirmatory Olmesartan Plaque Regression Study

Clinical trial NCT01132768 · TERMINATED

Trial details

NCT number: NCT01132768
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension Carotid Plaque

Start date: 2010-05-01
Primary completion: 2011-06-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.